A randomized, double-blind, crossover clinical trial of diclofenac plus misoprostol versus acetaminophen in patients with osteoarthritis of the hip or knee

Arthritis and Rheumatism

Volumn 44, Issue 7, 2001, Pages 1587-1598

  Pincus, T ^a,n   Koch, G G ^b   Sokka, T ^a,c   Lefkowith, J ^d   Wolfe, F ^e   Jordan, J M ^b   Luta, G ^b   Callahan, L F ^b   Wang, X ^b   Schwartz, T ^b   Abramson, S B ^f   Caldwell, J R ^g   Harrell, R A ^h   Kremer, J M ⁱ   Lautzenheiser, R L ^j   Markenson, J A ^k   Schnitzer, T J ^l   Weaver, A ^m   Cummins, P ^b   Wilson, A ^e   Morant, S ^e   Fort, J ^e   more..

^a VANDERBILT UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c JYVÄSKYLÄ CENTRAL HOSPITAL   (Finland)

^d PFIZER INC   (United States)

^e ARTHRITIS RESEARCH CENTER FOUNDATION   (United States)

^f NYU HOSPITAL FOR JOINT DISEASES   (United States)

^g Halifax Research Center   (United States)

^h Albany Medical College ^*

ⁱ ALBANY MEDICAL COLLEGE   (United States)

^j Rheumatology Associates   (United States)

^k HOSPITAL FOR SPECIAL SURGERY   (United States)

^l NORTHWESTERN UNIVERSITY   (United States)

^m Arthritis Center of Nebraska   (United States)

ⁿ VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DICLOFENAC; MISOPROSTOL; PARACETAMOL; PLACEBO;

ABDOMINAL PAIN; ACUTE ABDOMEN; ADULT; AGED; AMBULATORY CARE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COXITIS; CROSSOVER PROCEDURE; DIARRHEA; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DYSPEPSIA; FEMALE; HEART INFARCTION; HUMAN; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MALE; NAUSEA; PAIN ASSESSMENT; PRIORITY JOURNAL; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TREATMENT PLANNING; VOMITING;

ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTI-ULCER AGENTS; CROSS-OVER STUDIES; DICLOFENAC; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MISOPROSTOL; OSTEOARTHRITIS, HIP; OSTEOARTHRITIS, KNEE; PAIN MEASUREMENT; PATIENT SATISFACTION; TREATMENT OUTCOME;

EID: 0034945398     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200107)44:7<1587::AID-ART282>3.0.CO;2-X     Document Type: Article

References (44)

1. Estimates of the prevalence of selected arthritic and musculoskeletal diseases in the United States
2. Epidemiologic considerations in the primary prevention of osteoarthritis
3. Nonsteroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons
4. Nonsteroidal anti-inflammatory drug-associated gastropathy: Incidence and risk factor models
5. Toward an epidemiology of gastropathy associated with nonsteroidal anti-inflammatory drug use
6. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs
7. Guidelines for the medical management of osteoarthritis. Part I. Osteoarthritis of the hip
8. Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee
9. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update
10. Evaluation of acetaminophen in the management of osteoarthritis of the knee
11. Comparison of naproxen and acetaminophen in a two-year study of treatment of osteoarthritis of the knee
12. Comparison of an antiinflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee
13. Preference for nonsteroidal anti-inflammatory drugs over acetaminophen by rheumatic disease patients: A survey of 1,799 patients with osteoarthritis, rheumatoid arthritis, and fibromyalgia
14. Preference for nonsteroidal anti-inflammatory drugs versus acetaminophen and concomitant use of both types of drugs in patients with osteoarthritis
15. North of England evidence based guideline development project: Summary guideline for non-steroidal anti-inflammatory drugs versus basic analgesia in treating the pain of degenerative arthritis
16. Radiographic assessment of osteoarthrosis
17. Application of visual-analogue scales to the measurement of functional capacity
18. Measurement of patient outcome in arthritis
19. Toward a multidimensional health assessment questionnaire (MDHAQ): Assessment of advanced activities of daily living and psychological status in the patient-friendly health assessment questionnaire format
20. Validation study of WOMAC: A health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee
21. Pain assessment in osteoarthritis: Experience with the WOMAC osteoarthritis index
22. Double blind randomized controlled trial of sodium meclofenamate (Meclomen) and diclofenac sodium (Voltaren): Post validation reapplication of the WOMAC osteoarthritis index
23. Outcome measurement in osteoarthritis clinical trials
24. Design and conduct of clinical trials in patients with osteoarthritis: Recommendations from a task force of the Osteoarthritis Research Society
25. Validation study of the WOMAC: A health status instrument for measuring clinically-important patient relevant outcomes following total hip or knee arthroplasty in osteoarthritis
26. Assessment of patient satisfaction in activities of daily living using a modified Stanford health assessment questionnaire
27. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection
28. The MOS 36-Item Short-Form Health Survey (SF-36). II. Psychometric and clinical tests of validity in measuring physical and mental health constructs
29. Multiple testing of hypotheses in comparing two groups
30. Issues for covariance analysis of dichotomous and ordered categorical data from randomized clinical trials and non-parametric strategies for addressing them
31. Interpretation and power of pooled index
32. Is misoprostol prophylaxis indicated for NSAID induced adverse gastrointestinal events? An epidemiologic opinion
33. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs: A randomized, double-blind, placebo-controlled trial
34. Ibuprofen, acetaminophen and placebo in osteoarthritis of the knee: A six-day double-blind study
35. Limitations of randomized controlled clinical trials to recognize possible advantages of combination therapies in rheumatic diseases
36. Why randomized controlled clinical trials do not depict accurately long-term outcomes in rheumatoid arthritis: Some explanations and suggestions for future studies
37. Standard self-report questionnaires in routine clinical and research practice: An opportunity for patients and rheumatologists
38. Documenting quality management in rheumatic disease: Are patient questionnaires the best (and only) method?
39. Listening to the patient: A practical guide to self-report questionnaires in clinical care
40. Large-scale randomized evidence: Large, simple trials and overviews of trials
41. Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: A randomized controlled trial
42. Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: Results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip